149 related articles for article (PubMed ID: 36000799)
1. Mesoporous Polydopamine-Based Nanovehicles as a Versatile Drug Loading Platform to Enable Tumor-Sufficient Synergistic Therapy.
Jiang S; Zhu F; Ji X; Li J; Tian H; Wang B; Lu L; Wang P
ChemMedChem; 2022 Oct; 17(19):e202200360. PubMed ID: 36000799
[TBL] [Abstract][Full Text] [Related]
2. Multifunctional Mesoporous Polydopamine With Hydrophobic Paclitaxel For Photoacoustic Imaging-Guided Chemo-Photothermal Synergistic Therapy.
Zhang L; Yang P; Guo R; Sun J; Xie R; Yang W
Int J Nanomedicine; 2019; 14():8647-8663. PubMed ID: 31806962
[TBL] [Abstract][Full Text] [Related]
3. Mesoporous Doxorubicin-Loaded Polydopamine Nanoparticles Coated with a Platelet Membrane Suppress Tumor Growth in a Murine Model of Human Breast Cancer.
Ren D; Williams GR; Zhang Y; Ren R; Lou J; Zhu LM
ACS Appl Bio Mater; 2022 Jan; 5(1):123-133. PubMed ID: 35014822
[TBL] [Abstract][Full Text] [Related]
4. Hyaluronic Acid-Methotrexate Conjugates Coated Magnetic Polydopamine Nanoparticles for Multimodal Imaging-Guided Multistage Targeted Chemo-Photothermal Therapy.
Li Q; Chen Y; Zhou X; Chen D; Li Y; Yang J; Zhu X
Mol Pharm; 2018 Sep; 15(9):4049-4062. PubMed ID: 30011996
[TBL] [Abstract][Full Text] [Related]
5. Fabrication of doxorubicin-gated mesoporous polydopamine nanoplatforms for multimode imaging-guided synergistic chemophotothermal therapy of tumors.
Yang M; Zhang N; Zhang T; Yin X; Shen J
Drug Deliv; 2020 Dec; 27(1):367-377. PubMed ID: 32091284
[TBL] [Abstract][Full Text] [Related]
6. Delivery of Doxorubicin by Ferric Ion-Modified Mesoporous Polydopamine Nanoparticles and Anticancer Activity against HCT-116 Cells In Vitro.
Guo M; Ling J; Xu X; Ouyang X
Int J Mol Sci; 2023 Apr; 24(7):. PubMed ID: 37047825
[TBL] [Abstract][Full Text] [Related]
7. In vitro Antitumor Properties of Fucoidan-Coated, Doxorubicin-Loaded, Mesoporous Polydopamine Nanoparticles.
Xu H; Ling J; Zhao H; Xu X; Ouyang XK; Song X
Molecules; 2022 Dec; 27(23):. PubMed ID: 36500550
[TBL] [Abstract][Full Text] [Related]
8. Aptamer-conjugated mesoporous polydopamine for docetaxel targeted delivery and synergistic photothermal therapy of prostate cancer.
Dai L; Wei D; Zhang J; Shen T; Zhao Y; Liang J; Ma W; Zhang L; Liu Q; Zheng Y
Cell Prolif; 2021 Nov; 54(11):e13130. PubMed ID: 34599546
[TBL] [Abstract][Full Text] [Related]
9. Mesoporous polydopamine nanoparticles with co-delivery function for overcoming multidrug resistance via synergistic chemo-photothermal therapy.
Xing Y; Zhang J; Chen F; Liu J; Cai K
Nanoscale; 2017 Jun; 9(25):8781-8790. PubMed ID: 28621774
[TBL] [Abstract][Full Text] [Related]
10. Tumor targeting and penetrating biomimetic mesoporous polydopamine nanoparticles facilitate photothermal killing and autophagy blocking for synergistic tumor ablation.
Huang X; Chen L; Lin Y; Tou KI; Cai H; Jin H; Lin W; Zhang J; Cai J; Zhou H; Pi J
Acta Biomater; 2021 Dec; 136():456-472. PubMed ID: 34562660
[TBL] [Abstract][Full Text] [Related]
11. Programmed near-infrared light-responsive drug delivery system for combined magnetic tumor-targeting magnetic resonance imaging and chemo-phototherapy.
Feng Q; Zhang Y; Zhang W; Hao Y; Wang Y; Zhang H; Hou L; Zhang Z
Acta Biomater; 2017 Feb; 49():402-413. PubMed ID: 27890732
[TBL] [Abstract][Full Text] [Related]
12. cRGD-Conjugated Fe
Fan X; Yuan Z; Shou C; Fan G; Wang H; Gao F; Rui Y; Xu K; Yin P
Int J Nanomedicine; 2019; 14():9631-9645. PubMed ID: 31824156
[TBL] [Abstract][Full Text] [Related]
13. Construction of Surface-Modified Polydopamine Nanoparticles for Sequential Drug Release and Combined Chemo-Photothermal Cancer Therapy.
Wei C; Wang P; Huang Z; He D; Zhu W; Liu H; Chen Z; Wang W; Li Y; Shen J; Qin L
Mol Pharm; 2021 Mar; 18(3):1327-1343. PubMed ID: 33530691
[TBL] [Abstract][Full Text] [Related]
14. Near-infrared light triggered drug delivery system for higher efficacy of combined chemo-photothermal treatment.
Chen Y; Li H; Deng Y; Sun H; Ke X; Ci T
Acta Biomater; 2017 Mar; 51():374-392. PubMed ID: 28088668
[TBL] [Abstract][Full Text] [Related]
15. A novel self-coated polydopamine nanoparticle for synergistic photothermal-chemotherapy.
Chen H; Chen H; Wang Y; Bai Y; Yuan P; Che Z; Zhang L
Colloids Surf B Biointerfaces; 2021 Apr; 200():111596. PubMed ID: 33582445
[TBL] [Abstract][Full Text] [Related]
16. Sialic acid-engineered mesoporous polydopamine nanoparticles loaded with SPIO and Fe
Shu G; Chen M; Song J; Xu X; Lu C; Du Y; Xu M; Zhao Z; Zhu M; Fan K; Fan X; Fang S; Tang B; Dai Y; Du Y; Ji J
Bioact Mater; 2021 May; 6(5):1423-1435. PubMed ID: 33210034
[TBL] [Abstract][Full Text] [Related]
17. Polydopamine-coated mesoporous silica nanoparticles for multi-responsive drug delivery and combined chemo-photothermal therapy.
Lei W; Sun C; Jiang T; Gao Y; Yang Y; Zhao Q; Wang S
Mater Sci Eng C Mater Biol Appl; 2019 Dec; 105():110103. PubMed ID: 31546357
[TBL] [Abstract][Full Text] [Related]
18. Targeted polydopamine nanoparticles enable photoacoustic imaging guided chemo-photothermal synergistic therapy of tumor.
Li Y; Jiang C; Zhang D; Wang Y; Ren X; Ai K; Chen X; Lu L
Acta Biomater; 2017 Jan; 47():124-134. PubMed ID: 27721008
[TBL] [Abstract][Full Text] [Related]
19. Folic Acid-Modified Erythrocyte Membrane Loading Dual Drug for Targeted and Chemo-Photothermal Synergistic Cancer Therapy.
Chen Z; Wang W; Li Y; Wei C; Zhong P; He D; Liu H; Wang P; Huang Z; Zhu W; Zhou Y; Qin L
Mol Pharm; 2021 Jan; 18(1):386-402. PubMed ID: 33296217
[TBL] [Abstract][Full Text] [Related]
20. NIR-/pH-Responsive Nanocarriers Based on Mesoporous Hollow Polydopamine for Codelivery of Hydrophilic/Hydrophobic Drugs and Photothermal Synergetic Therapy.
Li S; Gan Y; Lin C; Lin K; Hu P; Liu L; Yu S; Zhao S; Shi J
ACS Appl Bio Mater; 2021 Feb; 4(2):1605-1615. PubMed ID: 35014509
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
